• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Enhabit, Inc. (NYSE:EHAB) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

    Simply Wall St·07/03/2025 10:47:34
    Listen to the news

    Enhabit, Inc. (NYSE:EHAB) shareholders won't be pleased to see that the share price has had a very rough month, dropping 26% and undoing the prior period's positive performance. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 12% in that time.

    After such a large drop in price, Enhabit's price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now compared to the Healthcare industry in the United States, where around half of the companies have P/S ratios above 0.9x and even P/S above 3x are quite common. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.

    This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

    Check out our latest analysis for Enhabit

    ps-multiple-vs-industry
    NYSE:EHAB Price to Sales Ratio vs Industry July 3rd 2025

    What Does Enhabit's Recent Performance Look Like?

    Enhabit could be doing better as its revenue has been going backwards lately while most other companies have been seeing positive revenue growth. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.

    Keen to find out how analysts think Enhabit's future stacks up against the industry? In that case, our free report is a great place to start.

    Do Revenue Forecasts Match The Low P/S Ratio?

    In order to justify its P/S ratio, Enhabit would need to produce sluggish growth that's trailing the industry.

    In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 1.1%. This means it has also seen a slide in revenue over the longer-term as revenue is down 7.0% in total over the last three years. Accordingly, shareholders would have felt downbeat about the medium-term rates of revenue growth.

    Looking ahead now, revenue is anticipated to climb by 4.9% per annum during the coming three years according to the six analysts following the company. Meanwhile, the rest of the industry is forecast to expand by 7.4% per year, which is noticeably more attractive.

    With this information, we can see why Enhabit is trading at a P/S lower than the industry. Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.

    What We Can Learn From Enhabit's P/S?

    Enhabit's P/S has taken a dip along with its share price. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.

    As expected, our analysis of Enhabit's analyst forecasts confirms that the company's underwhelming revenue outlook is a major contributor to its low P/S. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises. Unless these conditions improve, they will continue to form a barrier for the share price around these levels.

    The company's balance sheet is another key area for risk analysis. Our free balance sheet analysis for Enhabit with six simple checks will allow you to discover any risks that could be an issue.

    If you're unsure about the strength of Enhabit's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.